Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Farfield Expands International Patent Portfolio

Abstract:
Five New Patents Granted, Building on a Portfolio of Over 50 Applications Pending

Farfield Expands International Patent Portfolio

Crewe, UK | Posted on September 4th, 2007

Farfield Scientific Ltd (Crewe, UK) is delighted to announce it has recently been granted five further international patents related to its proprietary Dual Polarisation Interferometry (DPI) technology. Farfield prides itself in its innovative approach to using technology to provide next-generation scientific instruments to address the emerging and evolving measurement demands of 21st Century scientific progress. These latest patents are the most recent granted to Farfield from its pipeline of over 50 currently pending award. The patents granted are:

US Patent US 7,232,485 B2 describes the use of waveguides for the detection of nucleation events during the protein crystallisation process. This innovation was developed jointly with Daresbury Laboratory, Warrington, UK and allows protein crystallographers to optimise the conditions required for rapid crystal growth using only very small quantities of protein.

US Patent US 7,050,176 B1 is based on Farfield's unique DPI technology for measuring changes in dimension and composition of molecules caused by changes in chemical, biological or physical stimuli.

US Patent US 7,062,110 B2 describes the unique use of DPI as a method for measuring the partition coefficient of small molecules, such as pharmaceutical compounds.

European Patent 1305606 relates to a further embodiment of DPI in a compensated sensor geometry and Japanese Patent 10-523311 covers the waveguide technology underpinning Farfield's DPI measurements. The latter is a particularly broad ranging patent, with all 18 claims fully accepted, and embodies a completely new concept in measurement excellence.

Gerry Ronan, CEO at Farfield Scientific, comments "Farfield has pioneered the physical characterisation of bio-molecules, one of the most demanding measurement issues in biophysics. These recently-awarded patents, and our vast portfolio of applications pending, underpin our investment in what is a new field of scientific endeavour and confirm our undisputed market lead worldwide. Our protection now encompasses the USA, Europe and the Far East and we are delighted to have been successful in these applications."

####

About Farfield Scientific Ltd
Farfield Scientific is an innovator and global supplier of new analytical instruments that address the emerging and evolving measurement demands of the Surface Science, Nanotechnology and Biophysics communities. These communities provide the most demanding measurement challenges facing research over the next decade.

In Surface Science and Nanotechnology, Farfield develops and markets metrology solutions to the physical scientist, providing unique insights into the structural and functional behaviour of biomolecules, polymers and fine chemicals on a range of surfaces relevant to FMCG industries. Applications also include detailed characterisation of the molecular behaviour of biofilms and biocompatible surfaces, at market-leading levels of sensitivity and resolution.

In Biophysics, Farfield’s proprietary technology is the first that is capable of revealing the intimate and complex, relationship between structural change and function in biological molecules in real time, again at market-leading levels of sensitivity and resolution. Application areas include biophysical characterisation, structural and functional proteomics, biomolecular interaction studies, drug discovery, diagnostic development and biopharmaceutical analysis.

Since being founded in 1997, Farfield’s philosophy of innovation and analytical excellence has created a portfolio of scientific instruments based on quantifiable measurement and rigorous verification rooted in a thorough understanding of the principles of scientific measurement. This philosophy has won Farfield many international awards and support throughout the global research community. Farfield are committed to pursuing the ultimate in measurement at a sub-atomic scale, illuminating the molecular world.

For more information, please click here

Contacts:
Simon Carrington
Tel: +44 (0)870 950 9717

Copyright © Farfield Scientific Ltd

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Tools

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Caught on camera -- chemical reactions 'filmed' at the single-molecule level March 22nd, 2017

CRMGroup in Belgium uses a Deben three point bending stage in the development of new steel & coated steel products for automotive and other industrial applications March 21st, 2017

Next-gen steel under the microscope March 18th, 2017

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Intertronics introduce new nanoparticle deagglomeration technology March 15th, 2017

Keystone Nano Announces The US FDA Has Awarded Orphan Drug Designation For Ceramides For The Treatment Of Liver Cancer November 8th, 2016

Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project